A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
Active, not recruiting · Phase 2 · NCT06425302
Conditions: Lymphoma, Follicular
At a glance
- Research payments reported, 2025
- $6,001
- U.S. investigators named
- 10
- Sites paid
- 10
- Planned or actual enrollment
- 95
About the trial
- Sponsor
- Celgene
- Tested
- Golcadomide (drug), Rituximab (drug), Cyclophosphamide (drug), Doxorubicin (drug), Vincristine (drug), Prednisone (drug), Bendamustine (drug)
- Dates
- Started 2024-08-30; completion 2028-11-27
- Results posted
- Not yet
The purpose of this study is to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma (FL).
From ClinicalTrials.gov, last updated 2026-07-31. Full record, eligibility and contacts (opens in a new tab)
Industry funding
E.r. Squibb & Sons, L.l.c. reported $6,001 in research payments for this study in 2025 (10 payments).
Products named: Breyanzi
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Talal Hilal, M.D. Hematology & Oncology · Phoenix, AZ
- Jennifer L. Cultrera, M.D. Medical Oncology · Lady Lake, FL
- Eric M. Harris, D.O. Medical Oncology · Daytona Beach, FL
- Lakshmi Nayak, M.D. Medical Oncology · Boston, MA
- Sandeep S. Jain, MBBS Critical Care Medicine · Saint Cloud, MN
- Edwin C. Kingsley, MD Hematology & Oncology · Las Vegas, NV
- Michael Scordo Hematology & Oncology · New York, NY
- Krish Patel, M.D. Hematology & Oncology · Nashville, TN
- Ayushi Chauhan, M.D. Hematology & Oncology · Houston, TX
- Vyshak Alva Venur, M.D Medical Oncology · Seattle, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Florida Cancer Specialists $825
- University of Washington Medical Ctr, WA $823
- Ut MD Anderson Cancer Center $770
- Dana-Farber Cancer Institute $675
- Moffitt Cancer Center $646
- Memorial Sloan-Kettering Cancer Center - Cancer $645
- Scri Oncology PArtners $634
- Florida Cancer Specialists - North $585
- Mayo Clinic Hospital, AZ $290
- Comprehensive Cancer Centers of Nevada $108
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.